UNSPSC 51293008: Protriptyline

This classification denotes a tricyclic antidepressant with the molecular formula C19H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4NDU154T12, chemically known as 7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene but generally known as protriptyline, which bears US NIH Compound Identifier 4976. European Medicines Agency schedules Protriptyline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10145MIG. The term PROTRIPTYLINE is an International Non-Proprietary Name.

UNSPSC 51293008 Protriptyline is a Commodity code for a specific pharmaceutical product, yet the recent state and local procurement activity tagged under this code does not reflect protriptyline procurement. Seminole County, Florida released IFB 60459723LAS in June 2026 to source naloxone and drug deactivation systems — products outside the nominal scope of this code. The single recent opportunity shows a mismatch between the code assignment and the work actually being solicited, suggesting either a classification error in the county's procurement system or that protriptyline itself generates minimal state and local demand at present.

Seminole County's naloxone and deactivation-system procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually on an IFB basis with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, with an initial two-year contract term and optional one-year renewal. Bidders must meet standard compliance requirements, including drug-free workplace certification and E-Verify compliance, and the procurement was potentially funded through FEMA. Without additional recent opportunities tagged to UNSPSC 51293008 protriptyline, the code shows little relevant activity in state and local procurement markets.